Invion Ltd: Agreement with Major South Korean Pharma Group Hanlim
Invion Ltd: Activities Report and Appendix 4C
Invion Ltd: Presentation at East-West Summit in Singapore
Invion Ltd: INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC
Invion Ltd: Appendix 4D and Half Year Financial Report
Invion Ltd: Agreement with Dr.inB to develop Photosoft treatment for HPV
Invion Ltd: Activities Report and Appendix 4C
Invion Ltd: Change of Director's Interest Notice- Robert Merriel
Invion Ltd: Section 708A Cleansing Statement
Invion Ltd: Application for quotation of securities - IVX
Invion Ltd: Change of Auditor
Invion Ltd: Notification regarding unquoted securities - IVX
Invion Ltd: Results of Annual General Meeting
Invion Ltd: AGM Presentation
Invion Ltd: Major Milestone towards Clinical Trials
Invion Ltd: Notification of cessation of securities - IVX
Invion Ltd: Notice of Annual General Meeting/Proxy Form
Invion Ltd: Investor Presentation
Invion Ltd: Activities Report and Appendix 4C
Invion Ltd: Appendix 4G and Corporate Governance Statement
No Data